Skip to main content

What the FDA labels say about taking them together

Fosamprenavir and lidocaine

Fosamprenavir's FDA label of September 15, 2023 names lidocaine in its drug interactions section; the lidocaine labels PlainMeds reads (4) do not name fosamprenavir. The fosamprenavir label: “Therapeutic concentration monitoring, if available, is recommended for antiarrhythmics.”

Check it at the source: the fosamprenavir FDA label on DailyMed (effective September 15, 2023, Mylan Pharmaceuticals Inc.); the lidocaine FDA label on DailyMed (effective May 13, 2024, Fresenius Kabi USA, LLC).

What does the fosamprenavir label say about lidocaine?

Fosamprenavir label, drug interactions

Concomitant Drug Class/Drug Name: Antiarrhythmics: Amiodarone, disopyramide, lidocaine (systemic), and quinidine; Effect on Concentration of Amprenavir or Concomitant Drug: ↑ Antiarrhythmics; Clinical Comment: Therapeutic concentration monitoring, if available, is recommended for antiarrhythmics.

Source: FDA drug label (Fosamprenavir Calcium), Mylan Pharmaceuticals Inc., effective September 15, 2023 (SPL set 3a1424d8-844c-4e24-9ebd-b2c2b61b61a3), via openFDA; the full label on DailyMed

What does the lidocaine label say about fosamprenavir?

Lidocaine's label (effective May 13, 2024) and its 3 other brand-application labels do not name fosamprenavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Xylocaine MPF), Fresenius Kabi USA, LLC, effective May 13, 2024 (SPL set d5e0d06f-ba1e-44d4-aa89-39d6c146dc23), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

2Fosamprenavir generic labelers
81Lidocaine generic labelers
FosamprenavirLidocaine
Labeled forHIVPain
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.154 per gram 5% ointment
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?